Protein phosphatase 5 as a negative key regulator of Raf-1 activation

Trends in Endocrinology and Metabolism

Volumn 17, Issue 10, 2006, Pages 382-384

  Shah, Bukhtiar H ^a   Catt, Kevin J ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN PHOSPHATASE 5; RAF PROTEIN; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; ISOENZYME ANALYSIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE KINASE KINASES; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 33751172554     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2006.10.013     Document Type: Short Survey

References (14)

1. Normanno N., et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366 (2006) 2-16
2. Gollob J.A., et al. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin. Oncol. 33 (2006) 392-406
3. Shah B.H., and Catt K.J. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci. 27 (2004) 48-53
4. Citri A., and Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7 (2006) 505-516
5. O'Neill E., et al. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 306 (2004) 2267-2270
6. Baccarini M. Second nature: biological functions of the Raf-1 "kinase". FEBS Lett. 579 (2005) 3271-3277
7. von Kriegsheim A., et al. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nat. Cell Biol. 8 (2006) 1011-1016
8. Shah B.H., et al. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J. Biol. Chem. 278 (2003) 19118-19126
9. Chinkers M. Protein phosphatase 5 in signal transduction. Trends Endocrinol. Metab. 12 (2001) 28-32
10. Drysdale M.J., et al. Targeting Hsp90 for the treatment of cancer. Curr. Opin. Drug Discov. Devel 9 (2006) 483-495
11. Partch C.L., et al. Posttranslational regulation of the mammalian circadian clock by cryptochrome and protein phosphatase 5. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10467-10472
12. Liu F., et al. Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer's disease. J. Biol. Chem. 280 (2005) 1790-1796
13. Zhou G., et al. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J. Biol. Chem. 279 (2004) 46595-46605
14. Shah B.H., et al. Role of metalloproteinase-dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons. J. Neurochem. 96 (2006) 520-532